Screener/Healthcare/Biotechnology

VRDN

Viridian Therapeutics, Inc.NASDAQ
$27.24-0.38 (-1.38%)
Mid CapUnder $50HealthcareFastest Growing
$9.90
$34.29
$26.27
$27.48
EPS (TTM)$-3.32
P/E Ratio—
Dividend Yield—
Market Cap$2.55B
Volume1.02M
Prev Close$27.62
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$132K-$120.4M$-1.11—-91178.0%
Q3 '25$70.6M-$34.6M$-0.34—-49.0%
Q2 '25$75K-$100.7M$-1.00—-134313.3%
Q1 '25$72K-$86.9M$-0.87—-120711.1%
Q3 '24$86K-$76.7M$-1.15—-89173.3%
Q2 '24$72K-$65.0M$-1.02—-90268.1%
Q1 '24$72K-$48.5M$-0.79—-67419.4%
Q4 '23$72K-$66.9M$-1.34—-92861.1%
Get Your Daily Market Recap